DMI-Logo
search-iconsearch-icon

Metabolic Disorder Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Metabolic Disorder
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 September 13
Congenital Hyperinsulinism Treatment Market Size, Share, Trends and Forecast 2026-2035
Congenital hyperinsulinism treatment market reached US$ 171.9 million in 2025 and is projected to reach US$ 293.6 million by 2035, growing at a 5.5% CAGR during 2026–2035.
Starting from
$4350$2999
Published: 2026 August 29
Homocystinuria Market Size, Share, Industry, Forecast and Outlook 2026-2033
Homocystinuria Market reached US$ 412.62 million in 2025 and is expected to reach US$ 689.42 million by 2033
Starting from
$4350$2999
Published: 2026 July 31
NASH/MASH Treatment Market 2026-2035: Therapy Commercialization, Fibrosis Care and Growth Outlook
Track the NASH/MASH Treatment Market through 2035 as liver-directed drugs, incretin therapies, fibrosis staging and integrated metabolic care reshape treatment.
Starting from
$4350$2999
Published: 2026 July 25
Mucopolysaccharidoses Market Size, Share Analysis, Growth Insights and Forecast 2026-2033
The Global Mucopolysaccharidoses market reached US$ 2,486.6 million in 2025 and is expected to reach US$ 4,389.85 million by 2033, growing at a CAGR of 7.5% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 July 16
Hyperuricemia Market Size, Share, Industry, Forecast and Outlook (2026-2033)
Hyperuricemia Market reached US$ 1.89 billion in 2025 and is expected to reach US$ 4.01 billion by 2033, growing with a CAGR of 5.4% during the forecast period 2026-2033 | DataM Intelligence
Starting from
$4350$2999
Published: 2026 July 14
Lactose Intolerance Market Size, Share, Industry, Forecast and Outlook (2026-2033)
Lactose Intolerance Market reached US$ 26.2 billion in 2025 and is expected to reach US$ 45.4 billion by 2033, growing with a CAGR of 7.1%
Starting from
$4350$2999
Published: 2024 November 13
Nephrotic Syndrome Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Nephrotic Syndrome Drugs Market is estimated to grow at a CAGR of 5.4% during the forecast period 2024-2031
Starting from
$4350$2999
Published: 2025 September 16
Somatotropin Deficiency Treatment Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Explore the growth of the global somatotropin deficiency treatment market, key dynamics, major players, and COVID-19 impact. Learn about product approvals and regional trends
Starting from
$4350$2999
Published: 2024 December 16
Hyperammonemia Market Size, Share, Industry, Forecast and Outlook (2024-2031)
The Global Hyperammonemia Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.DataM Intelligence
Starting from
$4350$2999
Published: 2024 September 20
Alpha-mannosidosis Treatment Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Alpha-mannosidosis Treatment Market is expected to grow at a high CAGR during the forecast period 2024-2031
Starting from
$4350$2999